Compromise or Capitulation? US Food and Drug Administration Jurisdiction over Tobacco Products

Overview

Journal PLoS Med

Specialty General Medicine

Date 2009 Jul 29

PMID 19636359

Citations 5

Authors

Stanton A Glantz

Richard Barnes

Sharon Y Eubanks

Affiliations

Soon will be listed here.

Citing Articles

Striving to Meet Healthy People 2020 Objectives: Trend Analysis of Maternal Smoking.

Hansen A, Akomolafe T, McGalliard Z, Belle-Isle L, Zhang J Public Health Rep. 2018; 133(6):644-649.

PMID: 30278153 PMC: 6225881. DOI: 10.1177/0033354918793120.

Trends in Smoking and Smoking Cessation During Pregnancy from 1985 to 2014, Racial and Ethnic Disparity Observed from Multiple National Surveys.

Li H, Hansen A, McGalliard Z, Gover L, Yan F, Zhang J Matern Child Health J. 2018; 22(5):685-693.

PMID: 29397497 DOI: 10.1007/s10995-018-2437-x.

Tobacco Industry Research on Nicotine Replacement Therapy: "If Anyone Is Going to Take Away Our Business It Should Be Us".

Apollonio D, Glantz S Am J Public Health. 2017; 107(10):1636-1642.

PMID: 28817320 PMC: 5599147. DOI: 10.2105/AJPH.2017.303935.

Tobacco company efforts to influence the Food and Drug Administration-commissioned Institute of Medicine report clearing the smoke: an analysis of documents released through litigation.

Tan C, Kyriss T, Glantz S PLoS Med. 2013; 10(5):e1001450.

PMID: 23723740 PMC: 3665841. DOI: 10.1371/journal.pmed.1001450.

The toxic effects of cigarette additives. Philip Morris' project mix reconsidered: an analysis of documents released through litigation.

Wertz M, Kyriss T, Paranjape S, Glantz S PLoS Med. 2011; 8(12):e1001145.

PMID: 22205885 PMC: 3243707. DOI: 10.1371/journal.pmed.1001145.

References

Hirschhorn N, Bialous S . Second hand smoke and risk assessment: what was in it for the tobacco industry?. Tob Control. 2001; 10(4):375-82. PMC: 1747615. DOI: 10.1136/tc.10.4.375. View

McDaniel P, Smith E, Malone R . Philip Morris's Project Sunrise: weakening tobacco control by working with it. Tob Control. 2006; 15(3):215-23. PMC: 2564663. DOI: 10.1136/tc.2005.014977. View

Siegel M, Carol J, Jordan J, Hobart R, Schoenmarklin S, DuMelle F . Preemption in tobacco control. Review of an emerging public health problem. JAMA. 1997; 278(10):858-63. DOI: 10.1001/jama.278.10.858. View

Barnes D, Bero L . Industry-funded research and conflict of interest: an analysis of research sponsored by the tobacco industry through the Center for Indoor Air Research. J Health Polit Policy Law. 1996; 21(3):515-42. DOI: 10.1215/03616878-21-3-515. View

Bero L . Implications of the tobacco industry documents for public health and policy. Annu Rev Public Health. 2002; 24:267-88. DOI: 10.1146/annurev.publhealth.24.100901.140813. View

Farrelly M, Davis K, Haviland M, Messeri P, G Healton C . Evidence of a dose-response relationship between "truth" antismoking ads and youth smoking prevalence. Am J Public Health. 2005; 95(3):425-31. PMC: 1449196. DOI: 10.2105/AJPH.2004.049692. View

Barnes D, HANAUER P, Slade J, Bero L, Glantz S . Environmental tobacco smoke. The Brown and Williamson documents. JAMA. 1995; 274(3):248-53. DOI: 10.1001/jama.274.3.248. View

Barnes D, Bero L . Why review articles on the health effects of passive smoking reach different conclusions. JAMA. 1998; 279(19):1566-70. DOI: 10.1001/jama.279.19.1566. View

Hong M, Bero L . How the tobacco industry responded to an influential study of the health effects of secondhand smoke. BMJ. 2002; 325(7377):1413-6. PMC: 1124865. DOI: 10.1136/bmj.325.7377.1413. View

10.

Bero L, Galbraith A, Rennie D . Sponsored symposia on environmental tobacco smoke. JAMA. 1994; 271(8):612-7. View

11.

Ong E, Glantz S . Constructing "sound science" and "good epidemiology": tobacco, lawyers, and public relations firms. Am J Public Health. 2001; 91(11):1749-57. PMC: 1446868. DOI: 10.2105/ajph.91.11.1749. View

12.

Bero L . Tobacco industry manipulation of research. Public Health Rep. 2005; 120(2):200-8. PMC: 1497700. DOI: 10.1177/003335490512000215. View

13.

Givel M, Glantz S . The "global settlement" with the tobacco industry: 6 years later. Am J Public Health. 2004; 94(2):218-24. PMC: 1448231. DOI: 10.2105/ajph.94.2.218. View

14.

Farrelly M, Nonnemaker J, Davis K, Hussin A . The Influence of the National truth campaign on smoking initiation. Am J Prev Med. 2009; 36(5):379-84. DOI: 10.1016/j.amepre.2009.01.019. View

15.

Novotny T, Zhao F . Consumption and production waste: another externality of tobacco use. Tob Control. 1999; 8(1):75-80. PMC: 1763907. DOI: 10.1136/tc.8.1.75. View

16.

Barnes D, Bero L . Scientific quality of original research articles on environmental tobacco smoke. Tob Control. 1997; 6(1):19-26. PMC: 1759539. DOI: 10.1136/tc.6.1.19. View

17.

Borland R, Yong H, Wilson N, Fong G, Hammond D, Cummings K . How reactions to cigarette packet health warnings influence quitting: findings from the ITC Four-Country survey. Addiction. 2009; 104(4):669-75. PMC: 4394051. DOI: 10.1111/j.1360-0443.2009.02508.x. View

18.

Ling P, Neilands T, Glantz S . The effect of support for action against the tobacco industry on smoking among young adults. Am J Public Health. 2007; 97(8):1449-56. PMC: 1931473. DOI: 10.2105/AJPH.2006.098806. View

19.

Farrelly M, G Healton C, Davis K, Messeri P, Hersey J, Haviland M . Getting to the truth: evaluating national tobacco countermarketing campaigns. Am J Public Health. 2002; 92(6):901-7. PMC: 1447480. DOI: 10.2105/ajph.92.6.901. View

20.

Barnoya J, Glantz S . Tobacco industry success in preventing regulation of secondhand smoke in Latin America: the "Latin Project". Tob Control. 2002; 11(4):305-14. PMC: 1747685. DOI: 10.1136/tc.11.4.305. View